Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis.
Parker JL, Kuzulugil SS, Pereverzev K, Mac S, Lopes G, Shah Z, Weerasinghe A, Rubinger D, Falconi A, Bener A, Caglayan B, Tangri R, Mitsakakis N.
Parker JL, et al. Among authors: falconi a.
Cancer Med. 2021 Mar;10(6):1955-1963. doi: 10.1002/cam4.3732. Epub 2021 Feb 23.
Cancer Med. 2021.
PMID: 33620160
Free PMC article.